img

Nuclear Medicine/Radiopharmaceuticals


Published on: 2024-01-04 | No of Pages : 117 | Industry : Pharma & Healthcare

Publisher : HNY Research | Format : PDF&Excel

Nuclear Medicine/Radiopharmaceuticals

The global Nuclear Medicine/Radiopharmaceuticals market was valued at 5305.79 Million USD in 2021 and will grow with a CAGR of 8.16% from 2021 to 2027, based on HNY Research newly published report.

The prime objective of this report is to provide the insights on the post COVID-19 impact wwhich will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).

Radiopharmaceuticals (also known as radioactive drugs) are drugs that contain radionuclides that emit radiation. The distribution of the radiopharmaceutical within the body is determined by the physiochemical properties of the drug, the stability of the radiolabel, the purity of the radiopharmaceutical preparation, the pathophysiologic state of the patient, and the presence or absence of interfering drugs. Dynamic and static images of the distribution of the radiopharmaceutical within the body can be obtained using a g-camera or another suitable instrument appropriate for the radiopharmaceutical being imaged—for example, positronemitting radiopharmaceuticals.Nuclear medicine is a medical specialty that allows modern diagnostics and treatments using radiopharmaceuticals original radiotracers. Radiopharmaceuticals are considered a special group of drugs and thus their preparation and use are regulated by a set of policies that have been adopted by individual member countries. In China, radioactive drug approval process is cumbersome, drug research and development cycle is too long and the high-end equipment of China mainly relies on imports, which restrict the development of nuclear medicine.

By Market Verdors

China Isotope & Radiation

Dongcheng

Jaco

Ciaeriar

Advanced Molecular-imaging Solution

Shanghai Atom Kexing



By Types

Diagnostic

Therapeutic



By Applications

Oncology

Thyroid

Cardiology



Key Indicators Analysed

Market Players & Competitor AnalysisThe report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.

Global and Regional Market AnalysisThe report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.

Market TrendsMarket key trends which include Increased Competition and Continuous Innovations.

Opportunities and DriversIdentifying the Growing Demands and New Technology

Porters Five Force AnalysisThe report provides with the state of competition in industry depending on five basic forcesthreat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.



Key Reasons to Purchase

To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.

Assess the production processes, major issues, and solutions to mitigate the development risk.

To understand the most affecting driving and restraining forces in the market and its impact in the global market.

Learn about the market strategies that are being adopted by leading respective organizations.

To understand the future outlook and prospects for the market.

Besides the standard structure reports, we also provide custom research according to specific requirements

Table of Content

1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Players Covered: Ranking by Nuclear Medicine/Radiopharmaceuticals Revenue

1.4 Market Analysis by Type

1.4.1 Global Nuclear Medicine/Radiopharmaceuticals Market Size Growth Rate by Type: 2021 VS 2027

1.4.2 Diagnostic

1.4.3 Therapeutic

1.5 Market by Application

1.5.1 Global Nuclear Medicine/Radiopharmaceuticals Market Share by Application: 2022-2027

1.5.2 Oncology

1.5.3 Thyroid

1.5.4 Cardiology

1.6 Study Objectives

1.7 Years Considered

1.8 Overview of Global Nuclear Medicine/Radiopharmaceuticals Market

1.8.1 Global Nuclear Medicine/Radiopharmaceuticals Market Status and Outlook (2016-2027)

1.8.2 North America

1.8.3 East Asia

1.8.4 Europe

1.8.5 South Asia

1.8.6 Southeast Asia

1.8.7 Middle East

1.8.8 Africa

1.8.9 Oceania

1.8.10 South America

1.8.11 Rest of the World

2 Market Competition by Manufacturers

2.1 Global Nuclear Medicine/Radiopharmaceuticals Production Capacity Market Share by Manufacturers (2016-2021)

2.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Manufacturers (2016-2021)

2.3 Global Nuclear Medicine/Radiopharmaceuticals Average Price by Manufacturers (2016-2021)

2.4 Manufacturers Nuclear Medicine/Radiopharmaceuticals Production Sites, Area Served, Product Type

3 Sales by Region

3.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Volume Market Share by Region (2016-2021)

3.2 Global Nuclear Medicine/Radiopharmaceuticals Sales Revenue Market Share by Region (2016-2021)

3.3 North America Nuclear Medicine/Radiopharmaceuticals Sales Volume

3.3.1 North America Nuclear Medicine/Radiopharmaceuticals Sales Volume Growth Rate (2016-2021)

3.3.2 North America Nuclear Medicine/Radiopharmaceuticals Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

3.4 East Asia Nuclear Medicine/Radiopharmaceuticals Sales Volume

3.4.1 East Asia Nuclear Medicine/Radiopharmaceuticals Sales Volume Growth Rate (2016-2021)

3.4.2 East Asia Nuclear Medicine/Radiopharmaceuticals Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

3.5 Europe Nuclear Medicine/Radiopharmaceuticals Sales Volume (2016-2021)

3.5.1 Europe Nuclear Medicine/Radiopharmaceuticals Sales Volume Growth Rate (2016-2021)

3.5.2 Europe Nuclear Medicine/Radiopharmaceuticals Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

3.6 South Asia Nuclear Medicine/Radiopharmaceuticals Sales Volume (2016-2021)

3.6.1 South Asia Nuclear Medicine/Radiopharmaceuticals Sales Volume Growth Rate (2016-2021)

3.6.2 South Asia Nuclear Medicine/Radiopharmaceuticals Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

3.7 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales Volume (2016-2021)

3.7.1 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales Volume Growth Rate (2016-2021)

3.7.2 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

3.8 Middle East Nuclear Medicine/Radiopharmaceuticals Sales Volume (2016-2021)

3.8.1 Middle East Nuclear Medicine/Radiopharmaceuticals Sales Volume Growth Rate (2016-2021)

3.8.2 Middle East Nuclear Medicine/Radiopharmaceuticals Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

3.9 Africa Nuclear Medicine/Radiopharmaceuticals Sales Volume (2016-2021)

3.9.1 Africa Nuclear Medicine/Radiopharmaceuticals Sales Volume Growth Rate (2016-2021)

3.9.2 Africa Nuclear Medicine/Radiopharmaceuticals Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

3.10 Oceania Nuclear Medicine/Radiopharmaceuticals Sales Volume (2016-2021)

3.10.1 Oceania Nuclear Medicine/Radiopharmaceuticals Sales Volume Growth Rate (2016-2021)

3.10.2 Oceania Nuclear Medicine/Radiopharmaceuticals Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

3.11 South America Nuclear Medicine/Radiopharmaceuticals Sales Volume (2016-2021)

3.11.1 South America Nuclear Medicine/Radiopharmaceuticals Sales Volume Growth Rate (2016-2021)

3.11.2 South America Nuclear Medicine/Radiopharmaceuticals Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

3.12 Rest of the World Nuclear Medicine/Radiopharmaceuticals Sales Volume (2016-2021)

3.12.1 Rest of the World Nuclear Medicine/Radiopharmaceuticals Sales Volume Growth Rate (2016-2021)

3.12.2 Rest of the World Nuclear Medicine/Radiopharmaceuticals Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

4 North America

4.1 North America Nuclear Medicine/Radiopharmaceuticals Consumption by Countries

4.2 United States

4.3 Canada

4.4 Mexico

5 East Asia

5.1 East Asia Nuclear Medicine/Radiopharmaceuticals Consumption by Countries

5.2 China

5.3 Japan

5.4 South Korea

6 Europe

6.1 Europe Nuclear Medicine/Radiopharmaceuticals Consumption by Countries

6.2 Germany

6.3 United Kingdom

6.4 France

6.5 Italy

6.6 Russia

6.7 Spain

6.8 Netherlands

6.9 Switzerland

6.10 Poland

7 South Asia

7.1 South Asia Nuclear Medicine/Radiopharmaceuticals Consumption by Countries

7.2 India

7.3 Pakistan

7.4 Bangladesh

8 Southeast Asia

8.1 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Consumption by Countries

8.2 Indonesia

8.3 Thailand

8.4 Singapore

8.5 Malaysia

8.6 Philippines

8.7 Vietnam

8.8 Myanmar

9 Middle East

9.1 Middle East Nuclear Medicine/Radiopharmaceuticals Consumption by Countries

9.2 Turkey

9.3 Saudi Arabia

9.4 Iran

9.5 United Arab Emirates

9.6 Israel

9.7 Iraq

9.8 Qatar

9.9 Kuwait

9.10 Oman

10 Africa

10.1 Africa Nuclear Medicine/Radiopharmaceuticals Consumption by Countries

10.2 Nigeria

10.3 South Africa

10.4 Egypt

10.5 Algeria

10.6 Morocco

11 Oceania

11.1 Oceania Nuclear Medicine/Radiopharmaceuticals Consumption by Countries

11.2 Australia

11.3 New Zealand

12 South America

12.1 South America Nuclear Medicine/Radiopharmaceuticals Consumption by Countries

12.2 Brazil

12.3 Argentina

12.4 Columbia

12.5 Chile

12.6 Venezuela

12.7 Peru

12.8 Puerto Rico

12.9 Ecuador

13 Rest of the World

13.1 Rest of the World Nuclear Medicine/Radiopharmaceuticals Consumption by Countries

13.2 Kazakhstan

14 Sales Volume, Sales Revenue, Sales Price Trend by Type

14.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Volume Market Share by Type (2016-2021)

14.2 Global Nuclear Medicine/Radiopharmaceuticals Sales Revenue Market Share by Type (2016-2021)

14.3 Global Nuclear Medicine/Radiopharmaceuticals Sales Price by Type (2016-2021)

15 Consumption Analysis by Application

15.1 Global Nuclear Medicine/Radiopharmaceuticals Consumption Volume by Application (2016-2021)

15.2 Global Nuclear Medicine/Radiopharmaceuticals Consumption Value by Application (2016-2021)

16 Company Profiles and Key Figures in Nuclear Medicine/Radiopharmaceuticals Business

16.1 China Isotope & Radiation

16.1.1 China Isotope & Radiation Company Profile

16.1.2 China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Product Specification

16.1.3 China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.2 Dongcheng

16.2.1 Dongcheng Company Profile

16.2.2 Dongcheng Nuclear Medicine/Radiopharmaceuticals Product Specification

16.2.3 Dongcheng Nuclear Medicine/Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.3 Jaco

16.3.1 Jaco Company Profile

16.3.2 Jaco Nuclear Medicine/Radiopharmaceuticals Product Specification

16.3.3 Jaco Nuclear Medicine/Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.4 Ciaeriar

16.4.1 Ciaeriar Company Profile

16.4.2 Ciaeriar Nuclear Medicine/Radiopharmaceuticals Product Specification

16.4.3 Ciaeriar Nuclear Medicine/Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.5 Advanced Molecular-imaging Solution

16.5.1 Advanced Molecular-imaging Solution Company Profile

16.5.2 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Product Specification

16.5.3 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.6 Shanghai Atom Kexing

16.6.1 Shanghai Atom Kexing Company Profile

16.6.2 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Product Specification

16.6.3 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)

17 Nuclear Medicine/Radiopharmaceuticals Manufacturing Cost Analysis

17.1 Nuclear Medicine/Radiopharmaceuticals Key Raw Materials Analysis

17.1.1 Key Raw Materials

17.2 Proportion of Manufacturing Cost Structure

17.3 Manufacturing Process Analysis of Nuclear Medicine/Radiopharmaceuticals

17.4 Nuclear Medicine/Radiopharmaceuticals Industrial Chain Analysis

18 Marketing Channel, Distributors and Customers

18.1 Marketing Channel

18.2 Nuclear Medicine/Radiopharmaceuticals Distributors List

18.3 Nuclear Medicine/Radiopharmaceuticals Customers

19 Market Dynamics

19.1 Market Trends

19.2 Opportunities and Drivers

19.3 Challenges

19.4 Porter's Five Forces Analysis

20 Production and Supply Forecast

20.1 Global Forecasted Production of Nuclear Medicine/Radiopharmaceuticals (2022-2027)

20.2 Global Forecasted Revenue of Nuclear Medicine/Radiopharmaceuticals (2022-2027)

20.3 Global Forecasted Price of Nuclear Medicine/Radiopharmaceuticals (2016-2027)

20.4 Global Forecasted Production of Nuclear Medicine/Radiopharmaceuticals by Region (2022-2027)

20.4.1 North America Nuclear Medicine/Radiopharmaceuticals Production, Revenue Forecast (2022-2027)

20.4.2 East Asia Nuclear Medicine/Radiopharmaceuticals Production, Revenue Forecast (2022-2027)

20.4.3 Europe Nuclear Medicine/Radiopharmaceuticals Production, Revenue Forecast (2022-2027)

20.4.4 South Asia Nuclear Medicine/Radiopharmaceuticals Production, Revenue Forecast (2022-2027)

20.4.5 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Production, Revenue Forecast (2022-2027)

20.4.6 Middle East Nuclear Medicine/Radiopharmaceuticals Production, Revenue Forecast (2022-2027)

20.4.7 Africa Nuclear Medicine/Radiopharmaceuticals Production, Revenue Forecast (2022-2027)

20.4.8 Oceania Nuclear Medicine/Radiopharmaceuticals Production, Revenue Forecast (2022-2027)

20.4.9 South America Nuclear Medicine/Radiopharmaceuticals Production, Revenue Forecast (2022-2027)

20.4.10 Rest of the World Nuclear Medicine/Radiopharmaceuticals Production, Revenue Forecast (2022-2027)

20.5 Forecast by Type and by Application (2022-2027)

20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)

20.5.2 Global Forecasted Consumption of Nuclear Medicine/Radiopharmaceuticals by Application (2022-2027)

21 Consumption and Demand Forecast

21.1 North America Forecasted Consumption of Nuclear Medicine/Radiopharmaceuticals by Country

21.2 East Asia Market Forecasted Consumption of Nuclear Medicine/Radiopharmaceuticals by Country

21.3 Europe Market Forecasted Consumption of Nuclear Medicine/Radiopharmaceuticals by Countriy

21.4 South Asia Forecasted Consumption of Nuclear Medicine/Radiopharmaceuticals by Country

21.5 Southeast Asia Forecasted Consumption of Nuclear Medicine/Radiopharmaceuticals by Country

21.6 Middle East Forecasted Consumption of Nuclear Medicine/Radiopharmaceuticals by Country

21.7 Africa Forecasted Consumption of Nuclear Medicine/Radiopharmaceuticals by Country

21.8 Oceania Forecasted Consumption of Nuclear Medicine/Radiopharmaceuticals by Country

21.9 South America Forecasted Consumption of Nuclear Medicine/Radiopharmaceuticals by Country

21.10 Rest of the world Forecasted Consumption of Nuclear Medicine/Radiopharmaceuticals by Country

22 Research Findings and Conclusion

23 Methodology and Data Source

23.1 Methodology/Research Approach

23.1.1 Research Programs/Design

23.1.2 Market Size Estimation

23.1.3 Market Breakdown and Data Triangulation

23.2 Data Source

23.2.1 Secondary Sources

23.2.2 Primary Sources

23.3 Disclaimer



List of Figure

Key Players Covered: Ranking by Nuclear Medicine/Radiopharmaceuticals Revenue (US$ Million) 2016-2021

Global Nuclear Medicine/Radiopharmaceuticals Market Size by Type (US$ Million): 2022-2027

Global Nuclear Medicine/Radiopharmaceuticals Market Size by Application (US$ Million): 2022-2027

Global Nuclear Medicine/Radiopharmaceuticals Production Capacity by Manufacturers

Global Nuclear Medicine/Radiopharmaceuticals Production by Manufacturers (2016-2021)

Global Nuclear Medicine/Radiopharmaceuticals Production Market Share by Manufacturers (2016-2021)

Global Nuclear Medicine/Radiopharmaceuticals Revenue by Manufacturers (2016-2021)

Global Nuclear Medicine/Radiopharmaceuticals Revenue Share by Manufacturers (2016-2021)

Global Market Nuclear Medicine/Radiopharmaceuticals Average Price of Key Manufacturers (2016-2021)

Manufacturers Nuclear Medicine/Radiopharmaceuticals Production Sites and Area Served

Manufacturers Nuclear Medicine/Radiopharmaceuticals Product Type

Global Nuclear Medicine/Radiopharmaceuticals Sales Volume by Region (2016-2021)

Global Nuclear Medicine/Radiopharmaceuticals Sales Volume Market Share by Region (2016-2021)

Global Nuclear Medicine/Radiopharmaceuticals Sales Revenue by Region (2016-2021)

Global Nuclear Medicine/Radiopharmaceuticals Sales Revenue Market Share by Region (2016-2021)

North America Nuclear Medicine/Radiopharmaceuticals Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

East Asia Nuclear Medicine/Radiopharmaceuticals Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

Europe Nuclear Medicine/Radiopharmaceuticals Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

South Asia Nuclear Medicine/Radiopharmaceuticals Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

Middle East Nuclear Medicine/Radiopharmaceuticals Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

Africa Nuclear Medicine/Radiopharmaceuticals Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

Oceania Nuclear Medicine/Radiopharmaceuticals Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

South America Nuclear Medicine/Radiopharmaceuticals Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

Rest of the World Nuclear Medicine/Radiopharmaceuticals Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

North America Nuclear Medicine/Radiopharmaceuticals Consumption by Countries (2016-2021)

East Asia Nuclear Medicine/Radiopharmaceuticals Consumption by Countries (2016-2021)

Europe Nuclear Medicine/Radiopharmaceuticals Consumption by Region (2016-2021)

South Asia Nuclear Medicine/Radiopharmaceuticals Consumption by Countries (2016-2021)

Southeast Asia Nuclear Medicine/Radiopharmaceuticals Consumption by Countries (2016-2021)

Middle East Nuclear Medicine/Radiopharmaceuticals Consumption by Countries (2016-2021)

Africa Nuclear Medicine/Radiopharmaceuticals Consumption by Countries (2016-2021)

Oceania Nuclear Medicine/Radiopharmaceuticals Consumption by Countries (2016-2021)

South America Nuclear Medicine/Radiopharmaceuticals Consumption by Countries (2016-2021)

Rest of the World Nuclear Medicine/Radiopharmaceuticals Consumption by Countries (2016-2021)

Global Nuclear Medicine/Radiopharmaceuticals Sales Volume by Type (2016-2021)

Global Nuclear Medicine/Radiopharmaceuticals Sales Volume Market Share by Type (2016-2021)

Global Nuclear Medicine/Radiopharmaceuticals Sales Revenue by Type (2016-2021)

Global Nuclear Medicine/Radiopharmaceuticals Sales Revenue Share by Type (2016-2021)

Global Nuclear Medicine/Radiopharmaceuticals Sales Price by Type (2016-2021)

Global Nuclear Medicine/Radiopharmaceuticals Consumption Volume by Application (2016-2021)

Global Nuclear Medicine/Radiopharmaceuticals Consumption Volume Market Share by Application (2016-2021)

Global Nuclear Medicine/Radiopharmaceuticals Consumption Value by Application (2016-2021)

Global Nuclear Medicine/Radiopharmaceuticals Consumption Value Market Share by Application (2016-2021)

China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Dongcheng Nuclear Medicine/Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Jaco Nuclear Medicine/Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table Ciaeriar Nuclear Medicine/Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Nuclear Medicine/Radiopharmaceuticals Distributors List

Nuclear Medicine/Radiopharmaceuticals Customers List

Market Key Trends

Key Opportunities and Drivers: Impact Analysis (2022-2027)

Key Challenges

Global Nuclear Medicine/Radiopharmaceuticals Production Forecast by Region (2022-2027)

Global Nuclear Medicine/Radiopharmaceuticals Sales Volume Forecast by Type (2022-2027)

Global Nuclear Medicine/Radiopharmaceuticals Sales Volume Market Share Forecast by Type (2022-2027)

Global Nuclear Medicine/Radiopharmaceuticals Sales Revenue Forecast by Type (2022-2027)

Global Nuclear Medicine/Radiopharmaceuticals Sales Revenue Market Share Forecast by Type (2022-2027)

Global Nuclear Medicine/Radiopharmaceuticals Sales Price Forecast by Type (2022-2027)

Global Nuclear Medicine/Radiopharmaceuticals Consumption Volume Forecast by Application (2022-2027)

Global Nuclear Medicine/Radiopharmaceuticals Consumption Value Forecast by Application (2022-2027)

North America Nuclear Medicine/Radiopharmaceuticals Consumption Forecast 2022-2027 by Country

East Asia Nuclear Medicine/Radiopharmaceuticals Consumption Forecast 2022-2027 by Country

Europe Nuclear Medicine/Radiopharmaceuticals Consumption Forecast 2022-2027 by Country

South Asia Nuclear Medicine/Radiopharmaceuticals Consumption Forecast 2022-2027 by Country

Southeast Asia Nuclear Medicine/Radiopharmaceuticals Consumption Forecast 2022-2027 by Country

Middle East Nuclear Medicine/Radiopharmaceuticals Consumption Forecast 2022-2027 by Country

Africa Nuclear Medicine/Radiopharmaceuticals Consumption Forecast 2022-2027 by Country

Oceania Nuclear Medicine/Radiopharmaceuticals Consumption Forecast 2022-2027 by Country

South America Nuclear Medicine/Radiopharmaceuticals Consumption Forecast 2022-2027 by Country

Rest of the world Nuclear Medicine/Radiopharmaceuticals Consumption Forecast 2022-2027 by Country

Research Programs/Design for This Report

Key Data Information from Secondary Sources

Key Data Information from Primary Sources





Global Nuclear Medicine/Radiopharmaceuticals Market Share by Type: 2021 VS 2027

Diagnostic Features

Therapeutic Features

Global Nuclear Medicine/Radiopharmaceuticals Market Share by Application: 2021 VS 2027

Oncology Case Studies

Thyroid Case Studies

Cardiology Case Studies

Nuclear Medicine/Radiopharmaceuticals Report Years Considered

Global Nuclear Medicine/Radiopharmaceuticals Market Status and Outlook (2016-2027)

North America Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2016-2027)

East Asia Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2016-2027)

Europe Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2016-2027)

South Asia Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2016-2027)

South America Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2016-2027)

Middle East Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2016-2027)

Africa Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2016-2027)

Oceania Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2016-2027)

South America Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2016-2027)

Rest of the World Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2016-2027)

North America Nuclear Medicine/Radiopharmaceuticals Sales Volume Growth Rate (2016-2021)

East Asia Nuclear Medicine/Radiopharmaceuticals Sales Volume Growth Rate (2016-2021)

Europe Nuclear Medicine/Radiopharmaceuticals Sales Volume Growth Rate (2016-2021)

South Asia Nuclear Medicine/Radiopharmaceuticals Sales Volume Growth Rate (2016-2021)

Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales Volume Growth Rate (2016-2021)

Middle East Nuclear Medicine/Radiopharmaceuticals Sales Volume Growth Rate (2016-2021)

Africa Nuclear Medicine/Radiopharmaceuticals Sales Volume Growth Rate (2016-2021)

Oceania Nuclear Medicine/Radiopharmaceuticals Sales Volume Growth Rate (2016-2021)

South America Nuclear Medicine/Radiopharmaceuticals Sales Volume Growth Rate (2016-2021)

Rest of the World Nuclear Medicine/Radiopharmaceuticals Sales Volume Growth Rate (2016-2021)

North America Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

North America Nuclear Medicine/Radiopharmaceuticals Consumption Market Share by Countries in 2021

United States Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Canada Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Mexico Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

East Asia Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

East Asia Nuclear Medicine/Radiopharmaceuticals Consumption Market Share by Countries in 2021

China Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Japan Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

South Korea Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Europe Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate

Europe Nuclear Medicine/Radiopharmaceuticals Consumption Market Share by Region in 2021

Germany Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

United Kingdom Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

France Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Italy Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Russia Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Spain Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Netherlands Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Switzerland Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Poland Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

South Asia Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate

South Asia Nuclear Medicine/Radiopharmaceuticals Consumption Market Share by Countries in 2021

India Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Pakistan Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Bangladesh Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Southeast Asia Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate

Southeast Asia Nuclear Medicine/Radiopharmaceuticals Consumption Market Share by Countries in 2021

Indonesia Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Thailand Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Singapore Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Malaysia Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Philippines Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Vietnam Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Myanmar Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Middle East Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate

Middle East Nuclear Medicine/Radiopharmaceuticals Consumption Market Share by Countries in 2021

Turkey Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Saudi Arabia Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Iran Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

United Arab Emirates Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Israel Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Iraq Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Qatar Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Kuwait Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Oman Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Africa Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate

Africa Nuclear Medicine/Radiopharmaceuticals Consumption Market Share by Countries in 2021

Nigeria Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

South Africa Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Egypt Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Algeria Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Morocco Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Oceania Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate

Oceania Nuclear Medicine/Radiopharmaceuticals Consumption Market Share by Countries in 2021

Australia Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

New Zealand Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

South America Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate

South America Nuclear Medicine/Radiopharmaceuticals Consumption Market Share by Countries in 2021

Brazil Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Argentina Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Columbia Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Chile Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Venezuelal Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Peru Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Puerto Rico Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Ecuador Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Rest of the World Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate

Rest of the World Nuclear Medicine/Radiopharmaceuticals Consumption Market Share by Countries in 2021

Kazakhstan Nuclear Medicine/Radiopharmaceuticals Consumption and Growth Rate (2016-2021)

Sales Market Share of Nuclear Medicine/Radiopharmaceuticals by Type in 2021

Sales Revenue Market Share of Nuclear Medicine/Radiopharmaceuticals by Type in 2021

Global Nuclear Medicine/Radiopharmaceuticals Consumption Volume Market Share by Application in 2021

China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Product Specification

Dongcheng Nuclear Medicine/Radiopharmaceuticals Product Specification

Jaco Nuclear Medicine/Radiopharmaceuticals Product Specification

Ciaeriar Nuclear Medicine/Radiopharmaceuticals Product Specification

Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Product Specification

Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Product Specification

Manufacturing Cost Structure of Nuclear Medicine/Radiopharmaceuticals

Manufacturing Process Analysis of Nuclear Medicine/Radiopharmaceuticals

Nuclear Medicine/Radiopharmaceuticals Industrial Chain Analysis

Channels of Distribution

Distributors Profiles

Porter's Five Forces Analysis

Global Nuclear Medicine/Radiopharmaceuticals Production Capacity Growth Rate Forecast (2022-2027)

Global Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate Forecast (2022-2027)

Global Nuclear Medicine/Radiopharmaceuticals Price and Trend Forecast (2016-2027)

North America Nuclear Medicine/Radiopharmaceuticals Production Growth Rate Forecast (2022-2027)

North America Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate Forecast (2022-2027)

East Asia Nuclear Medicine/Radiopharmaceuticals Production Growth Rate Forecast (2022-2027)

East Asia Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate Forecast (2022-2027)

Europe Nuclear Medicine/Radiopharmaceuticals Production Growth Rate Forecast (2022-2027)

Europe Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate Forecast (2022-2027)

South Asia Nuclear Medicine/Radiopharmaceuticals Production Growth Rate Forecast (2022-2027)

South Asia Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate Forecast (2022-2027)

Southeast Asia Nuclear Medicine/Radiopharmaceuticals Production Growth Rate Forecast (2022-2027)

Southeast Asia Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate Forecast (2022-2027)

Middle East Nuclear Medicine/Radiopharmaceuticals Production Growth Rate Forecast (2022-2027)

Middle East Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate Forecast (2022-2027)

Africa Nuclear Medicine/Radiopharmaceuticals Production Growth Rate Forecast (2022-2027)

Africa Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate Forecast (2022-2027)

Oceania Nuclear Medicine/Radiopharmaceuticals Production Growth Rate Forecast (2022-2027)

Oceania Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate Forecast (2022-2027)

South America Nuclear Medicine/Radiopharmaceuticals Production Growth Rate Forecast (2022-2027)

South America Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate Forecast (2022-2027)

Rest of the World Nuclear Medicine/Radiopharmaceuticals Production Growth Rate Forecast (2022-2027)

Rest of the World Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate Forecast (2022-2027)

North America Nuclear Medicine/Radiopharmaceuticals Consumption Forecast 2022-2027

East Asia Nuclear Medicine/Radiopharmaceuticals Consumption Forecast 2022-2027

Europe Nuclear Medicine/Radiopharmaceuticals Consumption Forecast 2022-2027

South Asia Nuclear Medicine/Radiopharmaceuticals Consumption Forecast 2022-2027

Southeast Asia Nuclear Medicine/Radiopharmaceuticals Consumption Forecast 2022-2027

Middle East Nuclear Medicine/Radiopharmaceuticals Consumption Forecast 2022-2027

Africa Nuclear Medicine/Radiopharmaceuticals Consumption Forecast 2022-2027

Oceania Nuclear Medicine/Radiopharmaceuticals Consumption Forecast 2022-2027

South America Nuclear Medicine/Radiopharmaceuticals Consumption Forecast 2022-2027

Rest of the world Nuclear Medicine/Radiopharmaceuticals Consumption Forecast 2022-2027

Bottom-up and Top-down Approaches for This Report